Creative Capital Management Investments’s Globus Medical GMED Stock Holding History

Creative Capital Management Investments’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58K	Buy	+20	New	+$1.7K	﹤0.01%	918

Other funds holding GMED

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Creative Capital Management Investments's GMED Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Globus Medical (GMED) in Q2 2026: 20 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #918 among its holdings.

129 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Creative Capital Management Investments held 20 shares of Globus Medical worth $1.58K as of Q2 2026.
Globus Medical was a new Creative Capital Management Investments position in Q2 2026.
Globus Medical made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #918 holding.
129 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.